Medtronic says FY26 Impact Report shows 68% cut in Scope 1 and 2 emissions intensity vs FY20 baseline
Medtronic released its fiscal 2026 Impact Report, citing more than 82 million patients served worldwide. R&D investment totaled $2.9 billion, supporting more than 315 product approvals in major markets, including FDA clearance of the Hugo surgical robot. Quality nonconformances fell 70% through expanded First Time Qual